| For: | Diamantidis MD, Papaioannou M, Hatjiharissi E. Primary gastric non-Hodgkin lymphomas: Recent advances regarding disease pathogenesis and treatment. World J Gastroenterol 2021; 27(35): 5932-5945 [PMID: 34629810 DOI: 10.3748/wjg.v27.i35.5932] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i35/5932.htm |
| Number | Citing Articles |
| 1 |
Fanny Erika Palumbo, Calogero Vetro, Lucia Gozzo, Davide Giuseppe Castiglione, Paola De Luca, Andrea Duminuco. Second Primary Malignancies After Primary Gastric Lymphoma: Incidence, Risk Factors, and Clinical Implications. Hemato 2026; 7(2) doi: 10.3390/hemato7020017
|
| 2 |
Qiqi Qiao, Bingyu Liu, Juanjuan Shang, Wenyue Sun, Xiaoli Zhou, Xiaosheng Fang, Shunfeng Hu, Xin Wang. Metabolism-related ALDH1B1 acts as potential predictor and therapeutic target for primary gastrointestinal diffuse large B-cell lymphoma. Apoptosis 2025; 30(5-6) doi: 10.1007/s10495-025-02112-1
|
| 3 |
Natalia Botnaru-Dub. Unele consideraţii de aspecte clinice și tratament în limfoamele non-Hodgkin digestive. Public Health Economy and Management in Medicine 2026; (4(97)) doi: 10.52556/2587-3873.2023.4(97).18
|
| 4 |
Vignesh Krishnan Nagesh, Ruchi Bhuju, Ahmed S. Mohammed, Emelyn Martinez, Marina Basta, Deepa Francis, Shraboni Dey, Maggie James, Damien Islek, Sanket Bhattarai, Mohammed A. Saafan, Shruthi Badam, Adam Atoot. Gastrointestinal Lymphomas: A Comprehensive Review of Epidemiology, Clinical Features, Diagnosis, Histopathology, and Management. Lymphatics 2025; 3(4) doi: 10.3390/lymphatics3040031
|
| 5 |
|
| 6 |
Dandan Chen, Lili Jiang, Hongxun Tao. Upregulation of Actin-Related Protein 2 (ACTR2) Exacerbated the Malignancy of Diffuse Large B-Cell Lymphoma through Activating Wnt Signaling. Computational and Mathematical Methods in Medicine 2022; 2022 doi: 10.1155/2022/9351921
|
| 7 |
Natasa D. Zdravkovic, Vesna M. Grbovic, Radisa H. Vojinovic, Radojica V. Stolic, Jelena Z. Zivic, Mladen M. Maksic, Ziva P. Zivic, Nebojsa V. Andjelkovic, Milos Z. Zivic, Zeljko D. Todorovic. Ascites as First Atypical and Only Clinical Manifestation of De Novo Follicular Lymphoma. Medicina 2022; 58(10) doi: 10.3390/medicina58101381
|
| 8 |
Ziwei Wen, Xuemei He. The Value of Multiple Imaging Methods in Primary Gastric Lymphoma. Journal of Cancer Therapy 2023; 14(04) doi: 10.4236/jct.2023.144013
|
| 9 |
Minyue Zhang, Fei Xiao, Meisi Lin, Mengping Chen, Jian Hou, Honghui Huang. The epidemiology and prognosis of patients with primary gastric T‐cell lymphoma in the SEER program. Cancer Medicine 2023; 12(1) doi: 10.1002/cam4.4936
|
| 10 |
Jhumur Ghosh , Samia Hossain Sami, Jaya Ghosh. Non-Hodgkin’s Gastric Lymphoma: Case Report. Journal for Research in Applied Sciences and Biotechnology 2023; 2(1) doi: 10.55544/jrasb.2.1.14
|
| 11 |
M. S. Kazanchyan, Ya. S. Gaysultanova, N. V. Nikolaeva, A. V. Snezhko, I. B. Lysenko, L. Yu. Vladimirova, D. S. Petrov, Yu. A. Fomenko, E. N. Kolesnikov. Gastroenterostomy in non-Hodgkin B-cell lymphoma complicated by decompensated gastric outlet obstruction. South Russian Journal of Cancer 2026; 7(2) doi: 10.37748/2686-9039-2026-7-2-6
|
| 12 |
Bilal Niazi, Saad Ali, Sameh Elias, Michael Sciarra, Hirotada Akiho. Protein Loss Enteropathy as an Initial Presentation of Gastric Epstein–Barr Virus Lymphoma. Case Reports in Gastrointestinal Medicine 2022; 2022 doi: 10.1155/2022/5143760
|
| 13 |
Meeta Singh, Kirti Balhara, Deepika Rana, Rabish Kumar, Nimisha Dhankar, Shabnam Singh, Priyanka Bellichukki, Sreoshi Paul, Sathiyanesan Mariana Chartian. Advances in Fine Needle Aspiration Cytopathology. 2023; doi: 10.5772/intechopen.110607
|
| 14 |
Jin Won Kim, Dong-Han Yeom, Seon-Young Park, Seung-Young Seo, Hye-Su You, Ga-Ram You, Byung-Chul Jin, Jung-In Lee, Young-Dae Kim, Suck-Chei Choi, Wan-Sik Lee, Sung Sun Kim. Long-term clinical outcomes of gastric mucosa-associated lymphoid tissue lymphoma: a retrospective study in regions with a high prevalence of Helicobacter pylori infection. BMC Gastroenterology 2026; 26(1) doi: 10.1186/s12876-026-04699-4
|